American Cancer Society - Researchers at Massachusetts General Hospital (MGH) are testing a
non-surgical technique that may help doctors monitor how well non-small
cell lung cancer patients are responding to treatment. Using a device
known as a CTC-chip to analyze circulating tumor cells from patients’
blood samples, the scientists were able to identify whether patients
had genetic mutations that would […]










